Mon, Sep 15, 2014, 11:00 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.


  • ryanplume ryanplume Aug 6, 2013 8:47 AM Flag

    Speculation about the call does no good.

    In my history of trading this stock, Gary has yet to make a major scientific announcement or announce a business deal or partnership during a quarterly conference call. He's never announced anything that has caused a dramatic rise in share price during these things. He may have alluded to such an announcement, such as the Lancet, but nothing beyond that.

    These calls have always just been about providing a general update and overall direction or general announcements. Major PRs, scientific journals and everything else have always been separate from these calls.

    I kind of favor this approach, because then he is rewarding the holders of the stock and not the traders who try and trade around events like this.

    We often see a reasonable increase before these types of calls, nothing substantial or mind-blowing comes out and then the price falls back to where it was.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.08150.0000(0.00%)Aug 27 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT